Search

Paul Heylman has more than 40 years of experience representing clients in a broad range of maritime, labor and employment law, and employee benefits issues. Paul represents ports, ocean carriers, marine terminal operators and shippers before the Federal Maritime Commission in both litigation and...

Matt Antonelli is a commercial litigator who concentrates his practice on port and maritime law, as well as insurance coverage. Matt's experience in the maritime area includes assisting ports, ocean carriers, marine terminal operators and other entities dealing with matters under the Shipping Act...

Jay Reilly represents biotech, medical device and diagnostic companies, as well as universities and nonprofits, in strategic transactions in the life sciences industry, particularly complex collaborative arrangements and technology acquisitions and dispositions. Jay has extensive experience...

Dennis Ostrovsky assists clients with patent portfolios involving obtaining patents in diverse technologies such as nanomaterials, cellular analysis systems, small molecule drugs, bactericides, abrasives, drug delivery systems, dental compositions, volumetric additive manufacturing (VAM), OLED...

A patent attorney with a Ph.D. in Molecular Biology and Microbiology, Alireza Behrooz assists companies and universities in protecting intellectual property connected to inventions in the life sciences. Drawing on years of private practice experience, Alireza prepares, files and secures patents as...

Monaf Awwa, Ph.D., is a patent agent who helps clients in the biopharmaceutical, medical device and chemical industries protect their intellectual property by drafting their patent applications, preparing USPTO office action responses, and handling patent prosecutions. He also provides clients with...

Kevin M. Levy focuses primarily on real estate matters, including property sales and acquisitions, leases, commercial real estate lending and borrowing, development projects and real estate tax appeals. Kevin also advised clients on COVID-19 regulatory compliance and has commented extensively on...